Boehringer Ingelheim Revenue and Competitors

Ridgefield, CT USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Boehringer Ingelheim's estimated annual revenue is currently $10.2B per year.(i)
  • Boehringer Ingelheim's estimated revenue per employee is $228,614

Employee Data

  • Boehringer Ingelheim has 44584 Employees.(i)
  • Boehringer Ingelheim grew their employee count by 6% last year.

Boehringer Ingelheim's People

NameTitleEmail/Phone
1
Chairman and CEO for China, Hong Kong & Taiwan regionReveal Email/Phone
2
Global Process Owner & Global Data Platform Owner, Medical Literature and Information ScienceReveal Email/Phone
3
Assistant Management System OwnerReveal Email/Phone
4
Product Owner and Head iQNowReveal Email/Phone
5
Marketing Process Owner (MPO)Reveal Email/Phone
6
E2E Creative Services OwnerReveal Email/Phone
7
Management System OwnerReveal Email/Phone
8
Senior Data Scientist/Product Owner at BI XReveal Email/Phone
9
End 2 End Web Service OwnerReveal Email/Phone
10
Product OwnerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$69340M1073104%N/A$308.4B
#2
N/A108295-1%N/AN/A
Add Company

What Is Boehringer Ingelheim?

For more than 130 years, Boehringer Ingelheim has been committed to the research, development, and manufacturing of new medications with high therapeutic value for people and animals. As a family-owned pharmaceutical company, Boehringer Ingelheim is able to take a long-term view and invest heavily in research and development. We are proud of addressing some of the most challenging healthcare issues. Our vision – value through innovation – has always characterized our collaborative work, and is for us simultaneously a fundamental requirement and a driving force. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally through 145 affiliates and a total of some 47,500 employees

keywords:N/A

N/A

Total Funding

44584

Number of Employees

$10.2B

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Boehringer Ingelheim News

2022-04-20 - Boehringer Ingelheim Animal Health Plans $57M Expansion In Georgia

When complete, the expansion will bring Boehringer Ingelheim's Global Innovation footprint in Athens to nearly 115,000 square feet and...

2022-04-20 - José Manautou appointed Boehringer-Ingelheim ...

Chair in Mechanistic Toxicology. The endowed chair was established in 2006 with a gift of $1.2 million from Boehringer-Ingelheim Pharmaceuticals...

2022-04-20 - Boehringer Ingelheim launches initiative to promote heart ...

Boehringer Ingelheim is teaming with Eli Lilly and Co. on the new initiative Hear Your Heart, which is designed to empower Black and Latina...

2021-10-21 - Ex­clu­sive: Athi­ra CEO Leen Kawas re­signs af­ter in­ves­ti­ga­tion finds she ma­nip­u­lat­ed da­ta

Six years ago, Boehringer Ingelheim announced that a new manufacturing plant focused on large-scale cell culture technology would be erected in Vienna, marking the largest investment in the company’s history. Last week, the site became operational. The site will add another 185,000 liters of pr ...